fashion -WSS

fashion

author：knowledge 2025-09-28 19:25:42 - browse：25

A woman walks in San Francisco, with her father who has Alzheimer's – public health and science coverage from STAT — Ben Margot/AP

A host of hurdles are slowing the adoption of the new Alzheimer’s drug Leqembi, experts involved in the treatment of patients said Wednesday, from complicated logistics to the fact that many people don’t recognize that their memory loss is a disease soon enough.

Some patients still grapple with whether they want to be diagnosed, even though a treatment exists, the experts said, speaking during a STAT virtual event.

“Even the word for dementia does not always exist in every culture and in every language,” said Hollis Day, chief of geriatrics at Boston Medical Center and a professor at Boston University’s medical school. “And so just getting people to accept that memory loss is not normal aging necessarily, is a big barrier to getting people into diagnosis early enough to benefit from these treatments.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： FDA scientists endorse Pfizer/BioNTech Covid

WSS

'Null' research findings aren't empty of meaning. Let's publish them

It costs an awful lot of money to give away a kidney

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

FDA scientists endorse Pfizer/BioNTech Covid

Personalized medicine goes far beyond genetics

Grand jury probing Trump's efforts to overturn 2020 election did not meet Friday: Sources

hotspot

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

entertainment

ChatGPT in medicine: STAT answers readers' burning questions

What is artificial intelligence? Experts weigh in

Medicare details structure of new drug price negotiation program

Dispute over threat of extinction posed by artificial intelligence looms over surging industry

DIEP, the 'gold standard' of breast reconstruction, is under threat

CDC recommends RSV monoclonal antibody for infants

Peter Hotez and the public health issue of online harassment

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

Medicare proposal to cover medical devices draws a mixed reaction

What is the Turing Test that determines if computers can think?

knowledge

Florida babysitter arrested over hot car death, authorities say

Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

New chief aims to remake Sanofi Genzyme

Florida officials tell state schools to teach AP Psychology 'in its entirety'

A new deal aims to ramp up use of AI in rehab care decisions

focus

hotspot

focus

focus